Detalles de la búsqueda
1.
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?
Haematologica
; 109(3): 888-894, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37646655
2.
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity.
Blood
; 138(18): 1705-1720, 2021 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34077955
3.
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs.
Haematologica
; 105(1): 193-200, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31221778
4.
Transplant eligibility in elderly multiple myeloma patients: Prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65-75 years.
Am J Hematol
; 95(7): 759-765, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32242970
5.
Predictive role of sustained imaging MRD negativity assessed by diffusion-weighted whole-body MRI in multiple myeloma.
Am J Hematol
; 98(9): E230-E232, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37317959
6.
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.
Curr Osteoporos Rep
; 15(5): 499-506, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28889371
7.
Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study.
Cancer Med
; 12(9): 10254-10266, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36866838
8.
Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry.
Cancer Med
; 10(17): 5859-5865, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34263564
9.
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial.
Blood Cancer J
; 11(6): 106, 2021 06 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34083504
10.
Circulating microRNAs and Their Role in Multiple Myeloma.
Noncoding RNA
; 5(2)2019 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31052608
11.
Mechanism of cardiovascular toxicity by proteasome inhibitors: New paradigm derived from clinical and pre-clinical evidence.
Eur J Pharmacol
; 828: 80-88, 2018 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29550338
12.
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials.
Crit Rev Oncol Hematol
; 132: 9-16, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30447931
13.
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients.
Cancer Med
; 5(2): 265-74, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26715369
14.
Peripheral blood WT1 expression predicts relapse in AML patients undergoing allogeneic stem cell transplantation.
Biomed Res Int
; 2014: 123079, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25202702
Resultados
1 -
14
de 14
1
Próxima >
>>